CD44 and posterior cortical atrophy: We have demonstrated that PCa cell SP and holoclones, as well as CD44+ and CD44+α2β1+ subpopulations in some PCa models are enriched in prostate CSCs (PCSCs) with high tumorigenic and metastatic potential [6–12].